Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-28 @ 8:58 PM
Study NCT ID:
NCT05599932
Status:
COMPLETED
Last Update Posted:
2025-07-09
First Post:
2022-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-26
First Submit QC Date:
None
Study First Post Date:
2022-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-03
Last Update Post Date:
2025-07-09
Last Update Post Date Type:
ACTUAL